5-MeO-MPMI

5-MeO-MPMI
Legal status
Legal status	DE: NpSG (Industrial and scientific use only); UK: Class A;
Identifiers
	IUPAC name 5-Methoxy-3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-1H-indole;
CAS Number	143321-57-7 ;
PubChem CID	9881324;
ChemSpider	8057000 ;
UNII	N29TFW7VRV;
ChEMBL	ChEMBL137485 ;
CompTox Dashboard (EPA)	DTXSID401027538 ;
Chemical and physical data
Formula	C15H20N2O
Molar mass	244.338 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)OC;
	InChI InChI=1S/C15H20N2O/c1-17-7-3-4-12(17)8-11-10-16-15-6-5-13(18-2)9-14(11)15/h5-6,9-10,12,16H,3-4,7-8H2,1-2H3/t12-/m1/s1 ; Key:MKEGUJPBCIXABO-GFCCVEGCSA-N ;
	(what is this?) (verify)

5-MeO-MPMI (also known as 5-Methoxy-N-methyl-(α,N-trimethylene)tryptamine) is a pyrrolidinylmethylindole and cyclized tryptamine derivative that is a psychedelic drug. It was first developed by the team led by JE Macor in 1992,^[1] and subsequently investigated by the team led by David Nichols from Purdue University in the late 1990s. This compound produces psychedelic-appropriate responding in animal tests with a similar potency to the amphetamine-derived psychedelic DOI, and has two enantiomers, with only the (R)-enantiomer being active.^[2]

Quick facts Legal status, Identifiers ...

[1]

[2]

5-MeO-MPMI

See also

References

Wikiwand - on